Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume -, Issue -, Pages -
Publisher
Massachusetts Medical Society
Online
2023-06-15
DOI
10.1056/nejmoa2300709
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytosine Base Editing Enables Quadruple-Edited Allogeneic CAR-T Cells for T-ALL
- (2022) Caroline Diorio et al. BLOOD
- Frequent aneuploidy in primary human T cells after CRISPR–Cas9 cleavage
- (2022) Alessio David Nahmad et al. NATURE BIOTECHNOLOGY
- Genome edited allogeneic donor 'universal' chimeric antigen receptor T Cells
- (2022) Waseem Qasim BLOOD
- Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies
- (2022) Norihiro Watanabe et al. MOLECULAR THERAPY
- Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemia
- (2022) Giorgio Ottaviano et al. Science Translational Medicine
- Detection of chromosomal alteration after infusion of gene-edited allogeneic CAR T cells
- (2022) Barbra J. Sasu et al. MOLECULAR THERAPY
- Investigation of product derived lymphoma following infusion of piggyBac modified CD19 chimeric antigen receptor T-cells
- (2021) Kenneth Paul Micklethwaite et al. BLOOD
- Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial
- (2021) Jing Pan et al. JOURNAL OF CLINICAL ONCOLOGY
- Base-edited CAR T cells for combinational therapy against T cell malignancies
- (2021) Christos Georgiadis et al. LEUKEMIA
- Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline
- (2021) Bianca D. Santomasso et al. JOURNAL OF CLINICAL ONCOLOGY
- Eradication of T-ALL cells by CD7 targeted universal CAR-T cells and initial test of ruxolitinib-based CRS management
- (2020) Shiqi Li et al. CLINICAL CANCER RESEARCH
- Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
- (2020) Reuben Benjamin et al. LANCET
- How I Treat Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (T-ALL) and T-cell Lymphoblastic Lymphoma in Children
- (2019) David T Teachey et al. BLOOD
- An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies
- (2018) Matthew L Cooper et al. LEUKEMIA
- CRISPR-Mediated Base Editing Enables Efficient Disruption of Eukaryotic Genes through Induction of STOP Codons
- (2017) Pierre Billon et al. MOLECULAR CELL
- Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
- (2017) Waseem Qasim et al. Science Translational Medicine
- Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS Prodigy
- (2016) Ulrike Mock et al. CYTOTHERAPY
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search